Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ACTL6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WRAP73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRM3-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HTT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEFB126 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VENTXP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NENF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGPEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR8B8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FITM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA4G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDPD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INPP5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TTC38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on